These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24359498)

  • 1. The novel multi-target iron chelator, M30 modulates HIF-1α-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice.
    Mechlovich D; Amit T; Bar-Am O; Mandel S; Youdim MB; Weinreb O
    Curr Alzheimer Res; 2014 Feb; 11(2):119-27. PubMed ID: 24359498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30.
    Avramovich-Tirosh Y; Bar-Am O; Amit T; Youdim MB; Weinreb O
    Curr Alzheimer Res; 2010 Jun; 7(4):300-6. PubMed ID: 20043814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Weinreb O
    Antioxid Redox Signal; 2012 Sep; 17(6):860-77. PubMed ID: 22360429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.
    Kupershmidt L; Weinreb O; Amit T; Mandel S; Bar-Am O; Youdim MB
    Neuroscience; 2011 Aug; 189():345-58. PubMed ID: 21570450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular targets of the multifunctional iron-chelating drug, M30, in the brains of mouse models of type 2 diabetes mellitus.
    Mechlovich D; Amit T; Bar-Am O; Weinreb O; Youdim MB
    Br J Pharmacol; 2014 Dec; 171(24):5636-49. PubMed ID: 25073425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism.
    Pollak Y; Mechlovich D; Amit T; Bar-Am O; Manov I; Mandel SA; Weinreb O; Meyron-Holtz EG; Iancu TC; Youdim MB
    J Neural Transm (Vienna); 2013 Jan; 120(1):37-48. PubMed ID: 22446839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice.
    Kupershmidt L; Amit T; Bar-Am O; Weinreb O; Youdim MB
    Mol Neurobiol; 2012 Aug; 46(1):217-20. PubMed ID: 22847630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice.
    Kupershmidt L; Amit T; Bar-Am O; Youdim MB; Weinreb O
    Mech Ageing Dev; 2012 May; 133(5):267-74. PubMed ID: 22426424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis.
    Kupershmidt L; Weinreb O; Amit T; Mandel S; Carri MT; Youdim MB
    FASEB J; 2009 Nov; 23(11):3766-79. PubMed ID: 19638399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi target neuroprotective and neurorestorative anti-Parkinson and anti-Alzheimer drugs ladostigil and m30 derived from rasagiline.
    Youdim MB
    Exp Neurobiol; 2013 Mar; 22(1):1-10. PubMed ID: 23585716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models.
    Amit T; Bar-Am O; Mechlovich D; Kupershmidt L; Youdim MBH; Weinreb O
    Neuropharmacology; 2017 Sep; 123():359-367. PubMed ID: 28571715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.
    Weinreb O; Mandel S; Bar-Am O; Amit T
    J Neural Transm (Vienna); 2011 Mar; 118(3):479-92. PubMed ID: 21360301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Golko-Perez S; Mandel S; Amit T; Kupershmidt L; Youdim MB; Weinreb O
    Neurotox Res; 2016 Feb; 29(2):208-17. PubMed ID: 26581376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30.
    Youdim MB
    Curr Alzheimer Res; 2006 Dec; 3(5):541-50. PubMed ID: 17168653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerobic Glycolysis in the Frontal Cortex Correlates with Memory Performance in Wild-Type Mice But Not the APP/PS1 Mouse Model of Cerebral Amyloidosis.
    Harris RA; Tindale L; Lone A; Singh O; Macauley SL; Stanley M; Holtzman DM; Bartha R; Cumming RC
    J Neurosci; 2016 Feb; 36(6):1871-8. PubMed ID: 26865611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Effects of Multitarget Iron Chelator on Central Nervous System and Gastrocnemius Muscle in SOD1(G93A) Transgenic ALS Mice.
    Golko-Perez S; Amit T; Youdim MB; Weinreb O
    J Mol Neurosci; 2016 Aug; 59(4):504-10. PubMed ID: 27173029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Chinese herbal compound GAPT on the early brain glucose metabolism of APP/PS1 transgenic mice.
    Mana L; Feng H; Dong Y; Wang Y; Shi J; Tian J; Wang P
    Int J Immunopathol Pharmacol; 2019; 33():2058738419841482. PubMed ID: 30957587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Lactoferrin Enhances α-Secretase-Dependent Amyloid Precursor Protein Processing via the ERK1/2-CREB and HIF-1α Pathways in an Alzheimer's Disease Mouse Model.
    Guo C; Yang ZH; Zhang S; Chai R; Xue H; Zhang YH; Li JY; Wang ZY
    Neuropsychopharmacology; 2017 Dec; 42(13):2504-2515. PubMed ID: 28079060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
    Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.